1 d autoimmune polyglandular syndrome type 11 (Addison's disease, autoimmune insulin-dependent diabetes

2 ases, systemic sclerosis (3.59 [2.81-4.59]), Addison's disease (2.83 [1.96-4.09]), systemic lupus ery

3 a minor (8.00), lupoid hepatitis (5.75), and Addison disease (2.63).

4 us anemia, systemic lupus erythematosus, and Addison's disease.

5 lated disorders (e.g. Cushing's syndrome and Addison's disease).

6 truction of the adrenal glands in autoimmune Addison's disease remain unclear.

7 thematosus, celiac disease, Crohn's disease, Addison's disease, primary biliary cirrhosis, rheumatoid

8 ma, severe anemia, untreated hypothyroidism, Addison syndrome and major depression before treatment.

9 ntribute to diseases and syndromes including Addison's disease and Cushing syndrome.

10 +) T cell responses in a large proportion of Addison's patients both ex vivo and after in vitro cultu

11 betes also had significantly higher rates of Addison's disease (IRR 26.5 [95% CI 17.3-40.7]), coeliac

12 ion in the organ-specific Graves' disease or Addison's disease.

13 e effects, e.g., skin atrophy, osteoporosis, Addison-like adrenal insufficiency, fatty liver, and typ

14 renal insufficiency symptoms assessed by the Addison disease-specific quality of life questionnaire (

15 matoid arthritis, lupus, Graves thyroiditis, Addison disease and other autoimmune disorders.

16 une diseases including generalized vitiligo, Addison disease, type 1 diabetes, rheumatoid arthritis,

17 cific T cells detectable in 20 patients with Addison's disease.